Role of Erythropoietin Drugs in Reducing Blood Transfusions and...

added blog Yemek

2026-04-24 11:48:10

Role of Erythropoietin Drugs in Reducing Blood Transfusions and Improving Patient Outcomes

The global erythropoietin drugs market is poised for steady growth, driven by rising prevalence of chronic diseases and increasing focus on advanced anemia management. Valued at US$ 9.4 Bn in 2023, the market is projected to reach US$ 14.3 Bn by 2034, expanding at a CAGR of 3.8% during the forecast period. Understanding Erythropoietin Drugs Erythropoietin (EPO) drugs, also known as...

0 Comments 0 Shares 14 Views 0 Reviews